ADENOSINE-DEAMINASE-DEFICIENT MICE DIE PERINATALLY AND EXHIBIT LIVER-CELL DEGENERATION, ATELECTASIS AND SMALL-INTESTINAL CELL-DEATH

被引:101
作者
MIGCHIELSEN, AAJ
BREUER, ML
VANROON, MA
RIELE, HT
ZURCHER, C
OSSENDORP, F
TOUTAIN, S
HERSHFIELD, MS
BERNS, A
VALERIO, D
机构
[1] LEIDEN UNIV, SYLVIUS LABS, MOLEC CARCINOGENESIS LAB, GENE THERAPY WORKING GRP, 2300 RA LEIDEN, NETHERLANDS
[2] NETHERLANDS CANC INST, DIV MOLEC GENET, 1066 CX AMSTERDAM, NETHERLANDS
[3] TNO, BIOMED PRIMATE RES CTR, 2280 HV RIJSWIJK, NETHERLANDS
[4] ACAD HOSP LEIDEN, IMMUNOHEMATOL & BLOODBANK, LEIDEN, NETHERLANDS
[5] DUKE UNIV, MED CTR, DEPT RHEUMATOL & IMMUNOL, DURHAM, NC 27710 USA
[6] INTROGENE BV, 2280 GG RYSWIJK, NETHERLANDS
关键词
D O I
10.1038/ng0795-279
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We report the generation and characterization of mice lacking adenosine deaminase (ADA). in humans, absence of ADA causes severe combined immunodeficiency. In contrast, ADA-deficient mice die perinatally with marked liver-cell degeneration, but lack abnormalities in the thymus. The ADA substrates, adenosine and deoxyadenosine, are increased in ADA-deficient mice. Adenine deoxyribonucleotides are only modestly elevated, whereas S-adenosylhomocysteine hydrolase activity is reduced more than 85%. Consequently, the ratio of S-adenosylhomocysteine (AdoMet) to S-adenosyl homocysteine (AdoHcy) is reduced threefold in liver. We conclude that ADA plays a more critical role in murine than human fetal development. me murine liver pathology may be due to AdoHcy-mediated inhibition of AdoMet-dependent transmethylation reactions.
引用
收藏
页码:279 / 287
页数:9
相关论文
共 61 条
  • [1] ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803
  • [2] AKESON AL, 1988, J BIOL CHEM, V263, P16291
  • [3] EVIDENCE FOR A COMPLEX REGULATORY ARRAY IN THE 1ST INTRON OF THE HUMAN ADENOSINE-DEAMINASE GENE
    ARONOW, B
    LATTIER, D
    SILBIGER, R
    DUSING, M
    HUTTON, J
    JONES, G
    STOCK, J
    MCNEISH, J
    POTTER, S
    WITTE, D
    WIGINTON, D
    [J]. GENES & DEVELOPMENT, 1989, 3 (09) : 1384 - 1400
  • [4] PARADOXICAL EXPRESSION OF ADENOSINE-DEAMINASE IN T-CELLS CULTURED FROM A PATIENT WITH ADENOSINE-DEAMINASE DEFICIENCY AND COMBINED IMMUNODEFICIENCY
    ARREDONDOVEGA, FX
    KURTZBERG, J
    CHAFFEE, S
    SANTISTEBAN, I
    REISNER, E
    POVEY, MS
    HERSHFIELD, MS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) : 444 - 452
  • [5] IDENTICAL 3250-BP DELETION BETWEEN 2 ALUL REPEATS IN THE ADA GENES OF UNRELATED ADA-SCID PATIENTS
    BERKVENS, TM
    VANORMONDT, H
    GERRITSEN, EJA
    KHAN, PM
    VANDEREB, AJ
    [J]. GENOMICS, 1990, 7 (04) : 486 - 490
  • [6] MECHANISMS OF ELEVATION OF ADENOSINE LEVELS IN ANOXIC HEPATOCYTES
    BONTEMPS, F
    VINCENT, MF
    VANDENBERGHE, G
    [J]. BIOCHEMICAL JOURNAL, 1993, 290 : 671 - 677
  • [7] BUCHOU T, 1993, ONCOGENE, V8, P1765
  • [8] CARSON DA, 1980, J IMMUNOL, V124, P8
  • [9] DEVELOPMENTAL EXPRESSION OF ADENOSINE-DEAMINASE IN THE UPPER ALIMENTARY-TRACT OF MICE
    CHINSKY, JM
    RAMAMURTHY, V
    FANSLOW, WC
    INGOLIA, DE
    BLACKBURN, MR
    SHAFFER, KT
    HIGLEY, HR
    TRENTIN, JJ
    RUDOLPH, FB
    KNUDSEN, TB
    KELLEMS, RE
    [J]. DIFFERENTIATION, 1990, 42 (03) : 172 - 183
  • [10] DEOXYADENOSINE TRIPHOSPHATE AS A POTENTIALLY TOXIC METABOLITE IN ADENOSINE-DEAMINASE DEFICIENCY
    COHEN, A
    HIRSCHHORN, R
    HOROWITZ, SD
    RUBINSTEIN, A
    POLMAR, SH
    HONG, R
    MARTIN, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) : 472 - 476